GO:1900281 positive regulation of CD4-positive, alpha-beta T cell costimulation: Signaling Amplification, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1900281 describes any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell costimulation.
• Costimulation amplifies T cell receptor (TCR) signals and is essential for full CD4+ T cell activation, proliferation, and effector differentiation.
• Key costimulatory pathways include CD28-B7 and CD137 (4-1BB), which regulate CD4+ T cell homeostasis and follicular dendritic cell networks.
• Cytokines such as IL-10, TGF-beta, and IFN-alpha/beta modulate costimulation and CD4+ T cell priming in infection and vaccination.
• Dysregulated costimulation contributes to autoimmunity, chronic infection, and cancer immunosuppression.
• CRISPR knockout, knock-in, and overexpression models enable causal dissection of costimulatory genes in primary human and mouse T cells.
Description
Positive regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900281) is a biological process that increases the frequency, rate, or extent of costimulatory signaling in conventional CD4+ alpha-beta T cells. Costimulation provides the second signal required for full T cell activation after TCR engagement, and its positive regulation determines whether a CD4+ T cell becomes fully activated, anergic, or regulatory. This process is central to adaptive immunity, vaccine responses, and immune tolerance. Researchers study GO:1900281 to understand how costimulatory molecules such as CD28, CD137, and their ligands tune CD4+ T cell responses in infection, autoimmunity, and cancer. The term is also relevant to cytokine-mediated modulation of costimulation, including IL-10 and TGF-beta, which can suppress CD4+ T cell responses to pathogens such as Mycobacterium tuberculosis. Because costimulation is a rate-limiting step in T cell priming, positive regulators of this process are attractive targets for immunotherapy and vaccine adjuvant design.
positive regulation of CD4-positive, alpha-beta T cell costimulation At A Glance
| GO ID | GO:1900281 |
|---|---|
| GO term | positive regulation of CD4-positive, alpha-beta T cell costimulation |
| Ontology | biological_process |
| Synonym | activation of CD4-positive, alpha beta T cell costimulation; upregulation of CD4-positive, alpha beta T cell costimulation |
| Major function | Enhances costimulatory signaling that amplifies TCR-driven activation of CD4+ alpha-beta T cells |
| Key costimulatory molecules | CD28, CD137 (4-1BB), B7 ligands, CD40L |
| Modulating cytokines | IL-10, TGF-beta, IFN-alpha/beta |
| Related disease contexts | Autoimmunity, chronic infection, cancer immunosuppression |
What Is GO:1900281?
GO:1900281 is defined as any process that activates or increases the frequency, rate, or extent of CD4-positive, alpha-beta T cell costimulation. In practical terms, it covers molecular events that enhance the delivery or reception of costimulatory signals in CD4+ alpha-beta T cells, thereby promoting their activation, survival, proliferation, or effector function.
Why Is positive regulation of CD4-positive, alpha-beta T cell costimulation Important in Cell Biology?
Positive regulation of CD4-positive, alpha-beta T cell costimulation is critical because it sets the threshold for productive T cell activation and shapes the magnitude and quality of adaptive immune responses. Without adequate costimulation, CD4+ T cells may become anergic or undergo apoptosis, leading to impaired immunity; excessive costimulation can drive autoimmunity and inflammatory pathology. Understanding this process is therefore essential for vaccine design, cancer immunotherapy, and treatment of autoimmune diseases.
• Determines the threshold for full CD4+ T cell activation and prevents anergy.
• Shapes T helper differentiation and effector cytokine production.
• Regulates CD4/CD8 T cell homeostasis in vivo.
• Modulates immune responses to intracellular pathogens such as Mycobacterium tuberculosis.
• Influences priming of antigen-specific CD4+ T cells by DNA vaccines.
• Controls follicular dendritic cell networks via CD137 signaling.
• Contributes to autoimmunity when dysregulated.
• Represents a target for cancer immunotherapy and vaccine adjuvants.
• Can be suppressed by IL-10 and TGF-beta, affecting pathogen clearance.
• Provides a mechanistic basis for CRISPR screens in primary T cells.
What Happens During positive regulation of CD4-positive, alpha-beta T cell costimulation?
TCR engagement and costimulatory signal integration
In simple terms: The T cell first recognizes antigen, then receives a second 'go' signal from costimulatory molecules.
CD4+ alpha-beta T cells require both TCR engagement and costimulatory signals for full activation. Positive regulation of costimulation increases the strength or duration of the second signal, allowing the T cell to overcome activation thresholds and commit to proliferation and effector differentiation.
CD28-B7 and CD137 costimulatory pathways
In simple terms: Specific surface molecules act as accelerators for T cell activation.
The CD28-B7 pathway is a major costimulatory axis in CD4+ T cells, and its activity influences CD4/CD8 homeostasis. CD137 (4-1BB) signaling on activated T cells regulates follicular dendritic cell networks, demonstrating that positive costimulation can shape lymphoid tissue organization.
Cytokine modulation of costimulation
In simple terms: Cytokines can either boost or dampen the costimulatory signals.
IL-10 and TGF-beta regulate human CD4+ alpha-beta TCR+ T cell responses to Mycobacterium tuberculosis, indicating that cytokine environment can suppress or modulate costimulation. Conversely, IFN-alpha/beta promote priming of antigen-specific CD4+ T lymphocytes in immunostimulatory DNA-based vaccines, showing positive regulation by type I interferons.
CD40L and TCR-dependent regulation
In simple terms: Some costimulatory molecules are controlled mainly by the T cell receptor itself.
CD40 ligand (CD40L) expression on naive CD4 T cells is regulated by TCR signals but not by costimulatory signals, highlighting that positive regulation of costimulation operates in concert with TCR-driven programs.
Thymic development and CD4 lineage commitment
In simple terms: Costimulation also matters during T cell development in the thymus.
Thymocyte development through CD3 and maturation to the CD4+8+ stage are highly correlated, and costimulatory signals can influence these processes. Positive regulation of costimulation may therefore affect the generation of a functional CD4+ T cell repertoire.
Key Genes Involved in GO:1900281 positive regulation of CD4-positive, alpha-beta T cell costimulation
The following genes and proteins are central to positive regulation of CD4-positive, alpha-beta T cell costimulation, based on published functional studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CD28 | Primary costimulatory receptor on T cells | Target for enhancing or blocking CD4+ T cell activation |
| CD80 (B7-1) | Ligand for CD28/CTLA-4 | Regulates costimulation strength in CD4+ T cells |
| CD86 (B7-2) | Ligand for CD28/CTLA-4 | Modulates CD4/CD8 homeostasis |
| CD137 (4-1BB) | Costimulatory receptor on activated T cells | Regulates follicular dendritic cell networks |
| CD40LG (CD40L) | Costimulatory ligand on activated CD4+ T cells | TCR-regulated, not costimulation-regulated |
| IL10 | Immunosuppressive cytokine | Suppresses CD4+ T cell responses to M. tuberculosis |
| TGFB1 | Immunosuppressive cytokine | Regulates CD4+ alpha-beta T cell responses |
| IFNA1 | Type I interferon | Promotes priming of antigen-specific CD4+ T cells |
| IFNB1 | Type I interferon | Enhances CD4+ T cell priming in DNA vaccines |
| CD3E | TCR signaling component | Correlates with thymocyte maturation to CD4+8+ stage |
| CD4 | Coreceptor defining CD4+ lineage | Essential for MHC class II-restricted responses |
| TRB (TCR beta) | Antigen recognition subunit | Required for CD4+ alpha-beta T cell development |
| CD8A | Coreceptor on cytotoxic T cells | Used as comparator in CD4/CD8 homeostasis studies |
| FOXP3 | Regulatory T cell transcription factor | Downstream of costimulation in Treg development |
| TBX21 (T-bet) | Th1 transcription factor | Effector differentiation downstream of costimulation |
| GATA3 | Th2 transcription factor | Effector differentiation downstream of costimulation |
| RORC (RORgamma) | Th17 transcription factor | Effector differentiation downstream of costimulation |
How Is positive regulation of CD4-positive, alpha-beta T cell costimulation Regulated?
Positive regulation of CD4-positive, alpha-beta T cell costimulation is itself regulated at multiple levels. Cytokines such as IL-10 and TGF-beta can suppress costimulatory responses in human CD4+ alpha-beta T cells, while type I interferons (IFN-alpha/beta) enhance priming of antigen-specific CD4+ T cells. CD137 signaling on activated T cells regulates follicular dendritic cell networks, providing a feedback mechanism that shapes the costimulatory environment. TCR signal strength also controls expression of costimulatory ligands such as CD40L, which is regulated by TCR but not by costimulatory signals themselves. These layers of regulation ensure that costimulation is tightly coupled to the context of antigen recognition and the inflammatory milieu.
positive regulation of CD4-positive, alpha-beta T cell costimulation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CD28 | Autoimmunity, transplant rejection | CD28 knockout mouse or human T cell KO |
| CD137 (4-1BB) | Cancer, autoimmunity | CD137 agonist treatment in mouse models |
| IL10 | Chronic infection (M. tuberculosis) | IL-10 blockade in human PBMC cultures |
| TGFB1 | Fibrosis, chronic infection | TGF-beta neutralization in T cell assays |
| IFNA1/IFNB1 | Vaccine response, viral infection | DNA vaccine models with IFN-alpha/beta |
Autoimmunity and inflammatory disease
Excessive or dysregulated costimulation can lower the threshold for CD4+ T cell activation and contribute to autoimmunity. CD137 signaling, for example, regulates follicular dendritic cell networks that support autoreactive B cell responses, linking positive costimulation to autoimmune pathology.
Chronic infection and pathogen clearance
In chronic infections such as Mycobacterium tuberculosis, IL-10 and TGF-beta suppress CD4+ alpha-beta T cell responses, effectively reducing costimulation and impairing pathogen clearance. Conversely, vaccines that enhance costimulation can improve protective T cell responses even in CD4-deficient settings.
Cancer immunotherapy
Positive regulation of costimulation is a central goal of cancer immunotherapy, where agonists of costimulatory receptors such as CD137 are used to boost anti-tumor CD4+ and CD8+ T cell responses. DNA vaccines that promote CD4+ T cell priming via IFN-alpha/beta also illustrate the therapeutic potential of enhancing costimulation.
From positive regulation of CD4-positive, alpha-beta T cell costimulation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CD28 costimulation drive CD4+ T cell activation? | CD28 knockout mouse or CRISPR KO in primary human T cells |
| How does CD137 signaling affect follicular dendritic cells? | CD137 knockout or agonist-treated mouse models |
| Can IL-10 blockade restore CD4+ T cell costimulation? | IL-10 knockout or neutralizing antibody in M. tuberculosis infection |
| Do type I interferons enhance CD4+ T cell priming? | IFN-alpha/beta receptor knockout in DNA vaccination |
| Is CD40L expression TCR-dependent? | TCR transgenic CD4+ T cells with costimulation blockade |
| How does CD3 expression correlate with thymocyte maturation? | CD3epsilon knock-in or reporter mice |
How to Study the positive regulation of CD4-positive, alpha-beta T cell costimulation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Surface costimulatory molecule expression | CD28, CD137, CD40L on CD4+ T cells |
| CFSE dilution | T cell proliferation | Costimulation-driven division |
| ELISA | Cytokine secretion | IL-2, IFN-gamma after costimulation |
| Intracellular cytokine staining | Single-cell cytokine production | Antigen-specific CD4+ T cell responses |
| Adoptive transfer | In vivo T cell homeostasis | CD4/CD8 homeostasis studies |
| DNA vaccination | Antigen-specific T cell priming | IFN-alpha/beta enhancement |
| M. tuberculosis infection model | Protective T cell response | IL-10/TGF-beta modulation |
| CD137 agonist treatment | Follicular dendritic cell network | Lymphoid tissue organization |
Flow cytometry and activation marker analysis
Flow cytometry measures surface costimulatory molecules (CD28, CD137, CD40L) and activation markers (CD69, CD25) on CD4+ T cells after TCR stimulation. This method is standard for assessing positive regulation of costimulation in primary cells.
Cytokine production assays
ELISA or intracellular cytokine staining quantifies IL-2, IFN-gamma, and TNF-alpha production, which are downstream readouts of enhanced costimulation in CD4+ T cells.
Proliferation and CFSE dilution
CFSE or CellTrace dilution tracks CD4+ T cell division following costimulatory signals, providing a direct measure of positive regulation of costimulation.
In vivo infection and vaccination models
Mouse models of Mycobacterium tuberculosis infection or DNA vaccination assess how costimulation modulates antigen-specific CD4+ T cell priming and protective immunity.
How CRISPR Can Be Used to Study GO:1900281 positive regulation of CD4-positive, alpha-beta T cell costimulation
Knockout
CRISPR knockout of costimulatory genes such as CD28, CD137, or CD40LG in primary CD4+ T cells or mouse models can determine whether a candidate gene is required for positive regulation of costimulation. Knockout studies have shown that CD28-B7 interactions are critical for CD4/CD8 homeostasis.
Point Mutation
Point mutations can be introduced into costimulatory receptor cytoplasmic domains to dissect signaling motifs required for positive regulation. For example, mutating specific tyrosine residues in CD28 or CD137 can reveal which motifs drive costimulatory amplification.
Knock-in
Knock-in of reporter genes (e.g., GFP) or epitope tags into costimulatory loci allows tracking of expression and localization in CD4+ T cells. Tagged knock-in of CD40L or CD137 can reveal dynamic regulation during T cell activation.
Overexpression
Overexpression of costimulatory ligands such as CD80, CD86, or CD137L in antigen-presenting cells or tumor cells can enhance CD4+ T cell costimulation and boost immune responses in cancer or vaccine models.
How EDITGENE Supports positive regulation of CD4-positive, alpha-beta T cell costimulation Research
Researchers studying positive regulation of CD4-positive, alpha-beta T cell costimulation-related genes often need to determine whether a candidate gene is causally involved in enhancing or suppressing costimulatory signals. EDITGENE provides CRISPR-based cell model services to enable such causal studies in primary T cells and model cell lines.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of CD4-positive, alpha-beta T cell costimulation research.
Frequently Asked Questions About positive regulation of CD4-positive, alpha-beta T cell costimulation
What is GO:1900281?
GO:1900281 is the Gene Ontology term for positive regulation of CD4-positive, alpha-beta T cell costimulation, describing processes that increase the frequency, rate, or extent of costimulatory signaling in CD4+ alpha-beta T cells.
What genes are involved in positive regulation of CD4-positive, alpha-beta T cell costimulation?
Key genes include CD28, CD80, CD86, CD137, CD40LG, IL10, TGFB1, IFNA1, and IFNB1, based on functional studies.
Why is CD4-positive, alpha-beta T cell costimulation important?
It provides the second signal required for full CD4+ T cell activation, preventing anergy and enabling effective adaptive immunity.
How do cytokines regulate CD4+ T cell costimulation?
IL-10 and TGF-beta can suppress costimulation, while IFN-alpha/beta can enhance priming of antigen-specific CD4+ T cells.
What is the role of CD137 in costimulation?
CD137 (4-1BB) signaling on activated T cells regulates follicular dendritic cell networks, linking positive costimulation to lymphoid tissue organization.
Can CRISPR be used to study costimulation genes?
Yes, CRISPR knockout, knock-in, and overexpression models enable causal dissection of costimulatory genes in primary T cells and cell lines.
What diseases are linked to dysregulated CD4+ T cell costimulation?
Autoimmunity, chronic infections such as tuberculosis, and cancer immunosuppression are linked to altered costimulation.
How is CD40L expression regulated in naive CD4 T cells?
CD40L is regulated by TCR signals but not by costimulatory signals, as shown in naive CD4 T cells.
What methods are used to measure CD4+ T cell costimulation?
Flow cytometry, CFSE dilution, cytokine ELISA, and in vivo infection or vaccination models are commonly used.
What model systems are available for studying GO:1900281?
Knockout mice, CRISPR-edited primary human T cells, DNA vaccination models, and M. tuberculosis infection models are suitable.
Conclusion
GO:1900281, positive regulation of CD4-positive, alpha-beta T cell costimulation, is a central biological process that governs the strength and quality of CD4+ T cell activation. Its molecular players, including CD28, CD137, and cytokines such as IL-10 and IFN-alpha/beta, are well-documented in published literature. Understanding this process has direct implications for vaccine design, cancer immunotherapy, and autoimmune disease treatment. CRISPR-based models provide powerful tools to dissect the causal roles of individual genes in this pathway.
References
- 1. Yu X et al.. 2000. The role of B7 costimulation in CD4/CD8 T cell homeostasis.. J Immunol 164(7):3543-53 PMID: 10725709
- 2. Rojas RE et al.. 1999. Regulation of human CD4(+) alphabeta T-cell-receptor-positive (TCR(+)) and gammadelta TCR(+) T-cell responses to Mycobacterium tuberculosis by interleukin-10 and transforming growth factor beta.. Infect Immun 67(12):6461-72 PMID: 10569764
- 3. Cho HJ et al.. 2002. IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines.. J Immunol 168(10):4907-13 PMID: 11994440
- 4. Sun Y et al.. 2005. Regulation of follicular dendritic cell networks by activated T cells: the role of CD137 signaling.. J Immunol 175(2):884-90 PMID: 16002686
- 5. Fitch FW et al.. 1995. Regulation of T lymphocyte subsets.. Ciba Found Symp 195:68-80; discussion 80-5 PMID: 8724831
- 6. Levelt CN et al.. 1993. Regulation of thymocyte development through CD3. II. Expression of T cell receptor beta CD3 epsilon and maturation to the CD4+8+ stage are highly correlated in individual thymocytes.. J Exp Med 178(6):1867-75 PMID: 7504052
- 7. Derrick SC et al.. 2007. Characterization of the protective T-cell response generated in CD4-deficient mice by a live attenuated Mycobacterium tuberculosis vaccine.. Immunology 120(2):192-206 PMID: 17076705
- 8. Jaiswal AI et al.. 1996. Regulation of CD40 ligand expression on naive CD4 T cells: a role for TCR but not co-stimulatory signals.. Int Immunol 8(2):275-85 PMID: 8671613
